|
1.
|
|
23 p, 1.3 MB |
European guideline (EuroGuiDerm) on atopic eczema - part II : non-systemic treatments and treatment recommendations for special AE patient populations
/
Wollenberg, Andreas (Brussels University Hospital) ;
Kinberger, Maria (Charité - Berlin University Medicine) ;
Arents, B. (European Federation of Allergy and Airways Diseases Patients' Associations) ;
Aszodi, N. (LMU Munich) ;
Avila Valle, G. (Charité - Berlin University Medicine) ;
Barbarot, Sebastien (Nantes University) ;
Bieber, T. (University Hospital of Bonn) ;
Brough, H.A. (King's College London) ;
Calzavara Pinton, P. (University of Brescia) ;
Christen-Zäch, S. (Lausanne University Hospital) ;
Deleuran, M. (Aarhus University Hospital) ;
Dittmann, M. (Charité - Berlin University Medicine) ;
Dressler, C. (Charité - Berlin University Medicine) ;
Fink-Wagner, A.H. (Global Allergy and Airways diseases Patient Platform) ;
Fosse, N. (University Hospital Basel) ;
Gáspár, K. (University of Debrecen) ;
Gerbens, L. (Amsterdam UMC) ;
Gieler, U. (University of Giessen) ;
Girolomoni, Giampiero (University of Verona) ;
Gregoriou, S. (National and Kapodistrian University of Athens) ;
Mortz, C. G. (University of Southern Denmark) ;
Nast, A. (Charité - Berlin University Medicine) ;
Nygaard, U. (Aarhus University Hospital) ;
Redding, M. (Eczema Outreach Support) ;
Rehbinder, E.M. (Oslo University Hospital) ;
Ring, J. (Technical University Munich) ;
Rossi, M. (Spedali Civili Hospital Brescia) ;
Serra-Baldrich, E (Institut d'Investigació Biomèdica Sant Pau) ;
Simon, D. (University of Bern) ;
Szalai, Z.Z. (Heim Pál National Children's Institute Budapest) ;
Szepietowski, J.C. (Wrocław Medical University) ;
Torrelo, A. (Hospital Infantil Niño Jesús) ;
Werfel, T. (Hannover Medical School) ;
Flohr, C. (Guy's & St Thomas' NHS Foundation Trust) ;
Universitat Autònoma de Barcelona
The evidence- and consensus-based guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. Four consensus conferences were held between December 2020 and July 2021. [...]
2022 -  10.1111/jdv.18429
Journal of the European Academy of Dermatology and Venereology, Vol. 36 Núm. 11 (november 2022) , p. 1904-1926
|
|
|
2.
|
|
31 p, 3.2 MB |
Recent Advances in Potential Health Benefits of Quercetin
/
Aghababaei, Fatemeh (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ;
Hadidi, Milad (Universidad de Castilla-La Mancha)
Quercetin, a flavonoid found in fruits and vegetables, has been a part of human diets for centuries. Its numerous health benefits, including antioxidant, antimicrobial, anti-inflammatory, antiviral, and anticancer properties, have been extensively studied. [...]
2023 - 10.3390/ph16071020
Pharmaceuticals, Vol. 16 (july 2023)
|
|
|
3.
|
|
13 p, 2.0 MB |
Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI
/
Vilahur, Gemma (Institut d'Investigació Biomèdica Sant Pau) ;
Sutelman, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Ben-Aicha Gonzalez, Soumaya (Institut d'Investigació Biomèdica Sant Pau) ;
Mendieta, Guiomar (Institut d'Investigació Biomèdica Sant Pau) ;
Radiké, Monika (Institut d'Investigació Biomèdica Sant Pau) ;
Schoch, Leonie (Institut d'Investigació Biomèdica Sant Pau) ;
Casaní, Laura (Institut d'Investigació Biomèdica Sant Pau) ;
Borrell-Pages, Maria (Institut d'Investigació Biomèdica Sant Pau) ;
Padró, Teresa (Institut d'Investigació Biomèdica Sant Pau) ;
Badimon, Lina (Institut d'Investigació Biomèdica Sant Pau) ;
Universitat Autònoma de Barcelona
Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. [...]
2022 - 10.3389/fphar.2022.891801
Frontiers in Pharmacology, Vol. 13 (may 2022)
|
|
|
4.
|
|
7 p, 239.1 KB |
Association between chronic pain medications and the severity and mortality of COVID-19 : Study protocol for a case-population study
/
Serrano Afonso, Ancor (Institut d'Investigació Biomèdica de Bellvitge) ;
Pérez Hernández, Concepción (Hospital Universitario de la Princesa (Madrid)) ;
Ochoa Mazarro, Dolores (Hospital Universitario de la Princesa (Madrid)) ;
Román Martínez, Manuel (Hospital Universitario de la Princesa (Madrid)) ;
Failde Martínez, Inmaculada (Universidad de Cádiz) ;
Montes Pérez, Antonio (Institut Hospital del Mar d'Investigacions Mèdiques) ;
López Pais, P. (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Cánovas Martínez, Luz Noguero (Complejo Hospitalario Universitario de Ourense) ;
Revuelta Rizo, Miren (Institut d'Investigació Biomèdica Sant Pau) ;
Padilla-del-Rey, María-Luz (Complejo Hospitalario Universitario de Cartagena) ;
Peiró Perió, Ana (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Aberasturi Fueyo, Teresa (Hospital Comarcal Alt Penedes) ;
Margarit-Ferri, César (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Rojo Rodríguez, Elena (Hospital Universitario de la Princesa (Madrid)) ;
Mendiola de La Osa, Agustín (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Muñoz Martinez, Manuel José (Hospital Universitario de la Princesa (Madrid)) ;
Domínguez Bronchal, María Jesús (Complejo Hospitalario Universitario de Toledo) ;
Herrero Trujillano, Manuel (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ;
Cid Calzada, José (Complejo Hospitalario Universitario de Toledo) ;
Fabregat-Cid, Gustavo (Hospital General Universitario de Valencia) ;
Hernández-Cádiz, María José (Hospital General Universitario de Valencia) ;
Mareque Ortega, Manuel (Complejo Hospitalario Universitario de Toledo) ;
Gómez-Caro Álvarez Palencia, Leticia (Complejo Hospitalario Universitario de Toledo) ;
Mayoral Rojals, Víctor (Institut d'Investigació Biomèdica de Bellvitge)
In patients with coronavirus disease 2019 (COVID-19) infection, common drugs may exacerbate symptoms and negatively impact outcomes. However, the role of chronic medications on COVID-19 effects remains poorly understood. [...]
2021 - 10.1097/MD.0000000000026725
Medicine, Vol. 100 Núm. 30 (July 2021) , p. E26725
|
|
|
5.
|
|
9 p, 21.0 MB |
Robust in Vitro and in Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell
/
Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Vinyoles, Meritxell (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
López-Millán, Belén (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Díaz de la Guardia, Rafael (GENYO. Centro Pfizer-Universidad de Granada-Junta de Andalucia de Genomica e Investigacion Oncologica) ;
Atucha, Noemí M. (Universidad de Murcia) ;
Querol, Sergi (Banc de Sang i Teixits) ;
Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ;
Benitez, Raquel (Instituto de Parasitología y Biomedicina "López-Neyra") ;
Gonzalez-Rey, Elena (Instituto de Parasitología y Biomedicina "López-Neyra") ;
Delgado, Mario (Instituto de Parasitología y Biomedicina "López-Neyra") ;
Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
Mesenchymal stromal stem/cells (MSC) therapies are clinically used in a wide range of disorders based on their robust HLA-independent immunosuppressive and anti-inflammatory properties. However, the mechanisms underlying MSC therapeutic activity remain elusive as demonstrated by the unpredictable therapeutic efficacy of MSC infusions reported in multiple clinical trials. [...]
2022 - 10.1093/stcltm/szab007
Stem Cells Translational Medicine, Vol. 11 Núm. 1 (march 2022) , p. 88-96
|
|
|
6.
|
|
17 p, 1000.6 KB |
Optical control of adenosine A3 receptor function in psoriasis
/
López-Cano, Marc (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ;
Filgaira, Ingrid (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ;
Nolen, Ernest G. (Colgate University) ;
Cabré Segura, Gisela (Universitat Autònoma de Barcelona. Departament de Química) ;
Hernando Campos, Jordi (Universitat Autònoma de Barcelona. Departament de Química) ;
Tosh, Dilip K. (National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases (USA)) ;
Jacobson, Kenneth A. (National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases (USA)) ;
Soler, Concepció (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental) ;
Ciruela, Francisco (Universitat de Barcelona. Departament de Patologia i Terapèutica Experimental)
Psoriasis is a chronic and relapsing inflammatory skin disease lacking a cure that affects approximately 2% of the population. Defective keratinocyte proliferation and differentiation, and aberrant immune responses are major factors in its pathogenesis. [...]
2021 - 10.1016/j.phrs.2021.105731
Pharmacological Research, Vol. 170 (August 2021) , art. 105731
|
|
|
7.
|
|
16 p, 1.9 MB |
Swine as the Animal Model for Testing New Formulations of Anti-Inflammatory Drugs : Carprofen Pharmacokinetics and Bioavailability of the Intramuscular Route
/
Gómez-Segura, Lídia (Universitat Autònoma de Barcelona. Departament de Medicina i Cirurgia Animals) ;
Boix-Montañes, Antonio (Universitat de Barcelona. Institut de Nanociència i Nanotecnologia) ;
Mallandrich, Mireia (Universitat de Barcelona. Institut de Nanociència i Nanotecnologia) ;
Parra Coca, Alexander (University of Applied and Environmental Sciences. Department of Veterinary Medicine and Zootechnic) ;
Soriano-Ruiz, José L. (Universidad de Granada. Departamento de Farmacia) ;
Calpena-Campmany, Ana Cristina (Universitat de Barcelona. Institut de Nanociència i Nanotecnologia) ;
Gimeno, Álvaro (Universitat de Barcelona. Departament de Recerca Animal) ;
Bellido, David (Universitat de Barcelona. Centres Científics i Tecnològics) ;
Colom, Helena (Universitat de Barcelona. Institut de Nanociència i Nanotecnologia)
Carprofen (CP) is a non-steroidal anti-inflammatory drug (NSAID) frequently used to treat respiratory diseases in numerous small animals, but also in large species. CP is a formidable candidate for further therapeutic research of human inflammatory diseases using the pig as an animal model. [...]
2022 - 10.3390/pharmaceutics14051045
Pharmaceutics, Vol. 14 (may 2022)
|
|
|
8.
|
|
|
9.
|
|
22 p, 3.5 MB |
Recent Advances on Antimicrobial and Anti-Inflammatory Cotton Fabrics Containing Nanostructures
/
Granados Toda, Albert (Universitat Autònoma de Barcelona. Departament de Química) ;
Pleixats i Rovira, Roser (Universitat Autònoma de Barcelona. Departament de Química) ;
Vallribera Massó, Adelina (Universitat Autònoma de Barcelona. Departament de Química)
Hydrophilic cotton textiles, used in hospitals and sportswear, are prone to the growth of microorganisms (bacteria, fungi) resulting in hygiene and health risks. Thus, healthcare concerns have motivated the interest for the development of multifunctional antimicrobial cotton fabrics. [...]
2021 - 10.3390/molecules26103008
Molecules, Vol. 26, Num. 10 (May 2021) , art. 3008
|
|
|
10.
|
|
13 p, 1.5 MB |
Evaluation of an O 2-Substituted (1-3)-β-D-Glucan, Produced by Pediococcus parvulus 2.6, in ex vivo Models of Crohn's Disease
/
Notararigo, Sara (Instituto de Investigación Sanitaria de Santiago (IDIS)) ;
Varela, Encarnación (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ;
Otal, Anna (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cristobo, Iván (Centro de Investigaciones Biológicas (Madrid)) ;
Antolín, María (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Guarner, Francisco (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Prieto, Alicia (Centro de Investigaciones Biológicas (Madrid)) ;
López, Paloma (Centro de Investigaciones Biológicas (Madrid)) ;
Universitat Autònoma de Barcelona
1,3-β-glucans are extracellular polysaccharides synthesized by microorganisms and plants, with therapeutic potential. Among them, the O 2-substituted-(1-3)-β-D-glucan, synthesized by some lactic acid bacteria (LAB), has a prebiotic effect on probiotic strains, an immunomodulatory effect on monocyte-derived macrophages, and potentiates the ability of the producer strain to adhere to Caco-2 cells differentiated to enterocytes. [...]
2021 - 10.3389/fmicb.2021.621280
Frontiers in microbiology, Vol. 12 (february 2021)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
